LAUREN STANLEY: Open Payments
NPI 1982050001 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 34 payments from 7 companies in 2025. Trend: 2023 $311 · 2024 $553 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $293 |
| Novo Nordisk Inc | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Abbott Laboratories | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, UBRELVY, REXULTI, QULIPTA, Wegovy, Ozempic, FARXIGA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
